Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Change in Receivables (2016 - 2026)

United Therapeutics' Change in Receivables history spans 17 years, with the latest figure at $52.5 million for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 184.0% to $52.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.9 million, a 17625.0% increase, with the full-year FY2025 number at $70.9 million, up 17625.0% from a year prior.
  • Change in Receivables hit $52.5 million in Q4 2025 for United Therapeutics, up from -$81.6 million in the prior quarter.
  • Over the last five years, Change in Receivables for UTHR hit a ceiling of $138.1 million in Q2 2023 and a floor of -$85.9 million in Q1 2023.
  • Historically, Change in Receivables has averaged $9.6 million across 5 years, with a median of $11.5 million in 2022.
  • Biggest five-year swings in Change in Receivables: tumbled 858.82% in 2021 and later soared 4832.14% in 2023.
  • Tracing UTHR's Change in Receivables over 5 years: stood at -$14.1 million in 2021, then increased by 19.86% to -$11.3 million in 2022, then soared by 279.65% to $20.3 million in 2023, then plummeted by 407.88% to -$62.5 million in 2024, then surged by 184.0% to $52.5 million in 2025.
  • Business Quant data shows Change in Receivables for UTHR at $52.5 million in Q4 2025, -$81.6 million in Q3 2025, and $57.3 million in Q2 2025.